Image

BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities

BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities

Recruiting
5-18 years
All
Phase N/A

Powered by AI

Overview

The goal of this trial is to evaluate use of brain computer interfaces (BCI) at home for children with severe severe physical disabilities. The main questions it aims to answer are:

  1. Can a home BCI program enable children with disabilities to achieve personalized life participation goals?
  2. Can a home BCI program promote implementation reach?

Description

Preliminary research has proven that children with severe physical disabilities can operate home BCI systems. Despite the incredible impact of BCI on child well-being, access is currently limited to those who are close to major centres with the resources to frequently access tertiary care sites. A home-based BCI program is necessary to make this technology equitably available so that every child can realize their fundamental human right to participate in life.

The objectives are to: (1) Evaluate the effectiveness of a home BCI program for enabling children with disabilities to achieve personalized life participation goals; (2) Evaluate the equitable reach of implementation of a home BCI program.

This is a prospective, family-centered, single arm hybrid effectiveness-implementation trial that uses mixed methods. Implementation and effectiveness outcomes will be examined in parallel to ensure the program remains effective as its reach expands.

Implementation Methods: The trial uses systematic implementation science methods focused on the sustainable uptake of research into real-world practice. The four phases of the Quality Implementation Framework will guide implementation. Phase one focuses on identifying adaptations/strategies. Our transdisciplinary team will co-create four strategies to begin: 1) ready access to technical support, 2) scheduling flexibility, 3) broad choice of BCI activities, and 4) culturally safe care. Phase two focuses on creating a structure for implementation by formalizing plans and teams. The third phase, ongoing structure, will include monitoring and adapting strategies as needed during sequential participant enrolment. Phase four, improve future applications, will be done through evaluation outlined in outcomes below.

Home Program: Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.

Implementation Outcomes: The primary implementation outcome is the proportion of children recruited from equity-deserving groups. A baseline survey will capture comprehensive demographics. Secondary outcomes span the categories of the RE-AIM evaluation framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance). These outcomes will be continuously monitored with ongoing analysis using the appropriate descriptive statistics.

Effectiveness Outcomes: The primary effectiveness outcome is achievement of child and family-identified participation-based goals, as measured by the Canadian Occupational Performance Measure (COPM). Secondary outcomes will assess quality of life, family BCI experiences (via semi-structured interviews), and health economics. Primary analyses will assess the clinical and statistical significance of pre/post changes, and secondary regression analyses will explore potential response predictors including equity-deserving factors. Inductive thematic analysis will be used for interview transcripts. Finally, brain activity via electroencephalography (EEG) data from all BCI sessions will be captured. These data will be critical to accelerate options and accuracy of pediatric-focused BCI systems.

Eligibility

Inclusion Criteria:

  • Age 5-18 years
  • Severe motor impairment including inability to walk and minimal functional hand use, and/or;
  • Severe communication impairment
  • Ability to follow simple instructions and attend to simple tasks
  • Home environment suitable for the program based on clinician and family discussion;
  • Informed assent/consent

Exclusion Criteria:

  • Epileptic encephalopathy
  • Unstable epilepsy, or
  • Brain imaging incompatible with BCI functionality

Study details
    Cerebral Palsy
    Pediatric Stroke
    Genetic Condition
    Acquired Brain Injury (Including Stroke)

NCT07073378

University of Calgary

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.